Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia
Rasha W Al-Ali(Institute of Cancer Research), Christopher S. Hourigan(National Heart Lung and Blood Institute), Steven M. Devine(National Marrow Donor Program), Kristin Page(Medical College of Wisconsin), Antonio Jiménez(University of Miami), Zoë C. Wong(National Institutes of Health), Marcos de Lima(The Ohio State University), Devdeep Mukherjee(National Institutes of Health), Karina Elias(MesoScribe Technologies (United States)), Firas El Chaer(The University of Texas MD Anderson Cancer Center), Jeffrey E. Miller(MesoScribe Technologies (United States)), Austin Jacobsen(MesoScribe Technologies (United States)), Georgia Andrew(National Institutes of Health), Gege Gui(Johns Hopkins University), Scott L. Zeger(Johns Hopkins University), Wael Saber(Medical College of Wisconsin), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), R. Coleman Lindsley(Harvard University), Mark R. Litzow(Mayo Clinic in Arizona), Jeffery J. Auletta(Nationwide Children's Hospital), Stephen R. Spellman(National Marrow Donor Program), Jerald P. Radich(University of Washington), Ying Huang(MesoScribe Technologies (United States)), Matt Holman(MesoScribe Technologies (United States)), Jason Gerhold(MesoScribe Technologies (United States)), J. D'Angelo(MesoScribe Technologies (United States)), Laura W. Dillon(Institute of Cancer Research), Niveditha Ravindra(National Institutes of Health)
Cited by 2
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k